HEALTH

Huel launches ready-to-drink meal, additional innovations

BY DSN STAFF

Huel, a company that focuses on creating nutritionally complete meals that are convenient, affordable and have a minimum impact on the environment and animals, unveiled its latest innovations.

The Los Angeles-based company is launching Huel Ready-to-drink, new flavors of Flavor Boosts and reformulated v1.1 Pre-blend Powders. Each of the products are vegan and contain 27 essential vitamins and minerals, protein, essential fats, carbohydrates, fiber, and phytonutrients, the company said.

“We just recently shared our $26 million investor announcement with Highland Europe. We’re beyond thrilled to continue our growth and announce our newest launches, Huel Ready-to-drink, new flavors of the Flavor Boosts, and our reformulated v1.1 Powders,” Julian Hearn, co-founder of Huel, said. “While creating these new products, our consumers who are constantly on the go were at the forefront of our minds. We wanted to create new lines that offered a solution for everyone who feels they’re unable to consume nutritionally complete meals due to their hectic schedules. We know our U.S. consumers have given us their continued support and loyalty, which is why we’re committed to expanding and providing only nutritionally complete, affordable, sustainable meals for all.”

Huel’s Ready-to-drink product comes packaged in a 16.9-fl.-oz. bottle made out of 25% recycled plastic. It is gluten-free, soy-free, low in sugar and contains 20 g of plant-based protein, the company said.

The beverage, which is available in vanilla and berry flavors, will launch on Dec. 28. The Flavor Boosts will launch Nov. 29, and the v1.1 Pre-blend Powders can be purchased on Dec. 18. Further information on the products can be found on the company’s website.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

FDA cracks down on tianeptine claims

BY DSN STAFF

The Food and Drug Administration last week issued warning letters to two companies that the agency said were illegally marketing products containing tianeptine as dietary supplements. The FDA said the companies were illegally claiming tianeptine would treat opioid use disorder, pain and anxiety, among other claims, and that the action followed reports of adverse event caused by products with the ingredient.

Scott Gottlieb, the FDA commissioner, said the letters — to Jack B Goods Outlet Store for Tianaa Red, Tianaa White and Tianna Green products, and to MA Labs for Vicaine — were part of a larger effort the agency is undertaking to focus on safety and weed out potentially harmful products making untested claims.

“The bottom line is this: we’ve seen growing instances where profiteers are pushing potentially dangerous compounds — often with unproven drug claims and crossing the line when it comes to what defines a dietary supplement,” Gottlieb said. “These potentially illegal activities put the entire dietary supplement industry at risk by confusing consumers, harming patients and tainting good dietary supplement products by associating them with the activities of bad actors.”

The Council for Responsible Nutrition lauded the move from the FDA.

“[The] FDA demonstrated its continued commitment to public health and the agency’s dedication to protect consumers from illegal products falsely identified and marketed as dietary supplements,” CRN senior vice president of scientific and regulatory affairs Duffy MacKay said. “Companies selling these illegal products, labeled as containing tianeptine, are in direct violation of the federal law and are putting consumers’ health at risk. FDA knows of serious adverse events associated with tianeptine, and the agency is aware that these companies selling this ingredient are making dangerous claims, such as treating opioid use disorder.”

CRN noted that it had previously alerted consumers that there is no research to support using a supplement to treat opioid addiction, and it is illegal for supplement makers to market products with such claims.

“Consumer safety and access to safe products are important to both CRN and the FDA,” MacKay said. “CRN recommends that consumers seeking treatment of an opioid use disorder or addiction talk to a qualified healthcare professional or a public health authority.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

CHPA Foundation holds annual gala, adds board member

BY DSN STAFF

The Consumer Healthcare Products Association’s, or CHPA, Education Foundation held its third annual gala earlier in November, which was hosted by its chair Stephen Neumann.

Neumann also is the vice president of consumer insights and business intelligence at Bayer Consumer Health, and he was assisted by Anita Brikman, executive director of the CHPA Educational Foundation, and Mary Leonard, director of the CHPA Educational Foundation in his hosting duties.

“The gala is always such a great event to highlight the good work of the foundation, and we are thrilled to see participation continue to grow each year,” Neumann said. “It truly shows the level of support and dedication we have from donors across the industry.”

Highlighted throughout the night was the foundation’s work and achievements over the past year in educating consumers about the safe use, storage and disposal of over-the-counter medicines, with initiatives like the Acetaminophen Awareness Coalition’s Know Your Dose campaign and the Up and Away campaign, led by the U.S. Centers for Disease Control and Prevention and its PROTECT Initiative.

The CHPA Educational Foundation presented awards to three deserving honorees from the consumer health community:

  • CVS Health received this year’s Distinguished Industry Partner of the Year Award for championing the important issue of safe medicine storage. In June, CVS Health partnered with the foundation during National Safety Month to remind customers across 8,000 of its stores about the importance of putting medicines up, away, and out of sight and reach of young children;
  • The CDC Medication Safety Program won the Outstanding Community Partner of the Year Award for their ongoing leadership and commitment to keeping children safe from unintentional medication overdoses through the PROTECT Initiative and the Up and Away campaign; and
  • Bayer Consumer Health’s Coppertone + BrightGuard Partnership won the Industry Leadership Award for Advancing Responsible Self-Care Award. To address the importance of sun safety, Bayer Consumer Health and its Coppertone brand partnered with BrightGuard, the first automated sunscreen dispenser company to install sunscreen dispensers across the country this summer, representing more than 375,000 sunscreen applications supplied to the public for free.

“We are thrilled to honor our award winners this year,” Brikman said. “We had spectacular partnerships to showcase through our collaborations with CVS Health and the CDC Medication Safety Program on our Up and Away program. We also had several deserving nominations for our Industry Leadership Award. There is amazing work being done to advance responsible self-care with U.S. consumers. This year, Bayer Consumer Health’s Coppertone + BrightGuard Partnership ranked highest with our judges. Congratulations to all three of our award winners!”

In addition, the organization also welcomed Tom Corley, executive vice president, chief global retail officer and president of U.S. market at Catalina, to its board of directors.

“Tom is a wonderful addition to the CHPA Educational Foundation Board of Directors,” Neumann said. “He brings a wealth of knowledge on consumer behavior in the healthcare space and strategic ideas for partnerships that will help grow the foundation’s reach and impact.”

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?